Table 3.

Associations of diabetes severity with use of complementary medicine (CM)* to treat/manage type-2 diabetes

	UOR†	95% CI‡	AOR§	95% CI‡
Count of diabetes severity measures||
0-2 measures	ref		Ref
>=3 measures	1.27	.83-1.94	1.90	1.2-3.01
Individual measures of diabetes severity
DM duration
1-< 5 years	ref		Ref
5-<10 years	0.63	.34-1.18	0.70	.36-1.35
>= 10 years	1.15	.71-1.85	1.66	1.04-2.66
Diabetes medication use
None	ref		Ref
Any	0.63	.36-1.06	0.66	.36-1.19
Functional limitation
No	ref		Ref
Yes	1.47	.95-2.25	1.74	1.09-2.80
Weak/failing kidneys
No	ref		Ref
Yes	1.15	.53-2.47	1.46	.60-3.53
Coronary Heart Disease
No	ref		Ref
Yes	0.55	.28-1.10	0.87	.43-1.74
Severe vision problems
No	ref		Ref
Yes	1.1	.68-1.78	1.48	.85-2.57

* CM use, the dependent variable for this study, was defined as use of any of the following in the past 12 months: acupuncture, Ayurveda, biofeedback, chelation therapy, chiropractic care, chiropractic or osteopathic manipulation, energy healing therapy/Reiki, folk medicine, hypnosis, massage therapy, movement based therapies, naturopathy, herbal supplements and other non-vitamin/non-mineral dietary supplements (NVNMDS), homeopathic treatment, diet-based therapies, traditional healers, yoga, tai chi, qi gong, and relaxation techniques.

† unadjusted or crude odds ratio.

‡ 95% confidence interval.

§ Adjusted Odds Ratio. The model controls for socio-demographic and health status variables significantly associated (p < 0.1) with the dependent variables in Table  2: race/ethnicity, region of residence, number of co-morbid conditions, BMI level, the ability to perform vigorous leisure activity at least once per week and perceived health status, as well as for year of survey.

|| Based on the following six measures: 5 or more years since time of diagnosis, use of insulin or oral hypoglycemic drugs, at least one functional limitation attributed to the diabetes, weak or failing kidneys, Coronary Heart Disease, and severe vision problems.